Alto Neuroscience (ANRO) News Today $4.17 +0.23 (+5.81%) As of 03:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANRO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Class Action Filed Against Alto Neuroscience, Inc. (ANRO) Seeking Recovery for Investors - Contact Levi & KorsinskyAugust 26 at 8:46 AM | prnewswire.comAlto Neuroscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 19, 2025 to Discuss Your Rights – ANROAugust 25 at 5:11 PM | globenewswire.comANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alto Neuroscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 25 at 4:00 PM | globenewswire.comROSEN, A TOP RANKED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANROAugust 25 at 3:10 PM | markets.businessinsider.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc.and Certain Officers – ANROAugust 25 at 10:30 AM | globenewswire.comInvestors who lost money on Alto Neuroscience, Inc.(ANRO) should contact The Gross Law Firm about pending Class Action - ANROAugust 25 at 8:45 AM | prnewswire.comSHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Alto Neuroscience, Inc. (NYSE: ANRO)August 25 at 8:19 AM | globenewswire.comROSEN, A TOP RANKED LAW FIRM, Encourages Alto Neuroscience, Inc. ...August 24 at 12:30 PM | gurufocus.comROSEN, A TOP RANKED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANROAugust 24 at 11:31 AM | globenewswire.comANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud LawsuitAugust 22, 2025 | prnewswire.comContact Levi & Korsinsky by September 19, 2025 Deadline to Join Class Action Against Alto Neuroscience, Inc.(ANRO)August 22, 2025 | globenewswire.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto NeuroscienceAugust 22, 2025 | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. and Certain Officers - ANROAugust 22, 2025 | prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. Lawsuit - ANROAugust 22, 2025 | prnewswire.comHC Wainwright Issues Pessimistic Outlook for ANRO EarningsAugust 22, 2025 | marketbeat.comInvestors in Alto Neuroscience, Inc. Should Contact Levi & Korsinsky Before September 19, 2025 to Discuss Your Rights - ANROAugust 22, 2025 | theglobeandmail.comROSEN, A LONGSTANDING LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANROAugust 21, 2025 | globenewswire.comThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Alto Neuroscience, Inc. (ANRO) ShareholdersAugust 21, 2025 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto NeuroscienceAugust 21, 2025 | prnewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc.and Certain Officers – ANROAugust 21, 2025 | globenewswire.comPromising Pipeline and Expert Backing Drive Buy Rating for Alto Neuroscience, Inc.August 21, 2025 | tipranks.comShareholders of Alto Neuroscience, Inc. Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights - ANROAugust 21, 2025 | prnewswire.comAlto Neuroscience, Inc. (NYSE:ANRO) Receives $8.50 Average Target Price from AnalystsAugust 21, 2025 | americanbankingnews.comAlto Neuroscience's (ANRO) Buy Rating Reiterated at HC WainwrightAugust 20, 2025 | marketbeat.comAlto Neuroscience’s Depression Drug Shows Positive Biomarker Results in Phase 2 TrialAugust 20, 2025 | msn.comHC Wainwright Reaffirms Buy Rating for Alto Neuroscience (NYSE:ANRO)August 20, 2025 | americanbankingnews.comShareholders that lost money on Alto Neuroscience, Inc. (ANRO) Urged to Join Class Action – Contact Levi & Korsinsky to Learn MoreAugust 19, 2025 | globenewswire.comAlto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi ...August 19, 2025 | gurufocus.comAlto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 19, 2025 to Discuss Your Rights - ANROAugust 19, 2025 | prnewswire.comAlto Neuroscience, Inc. (NYSE:ANRO) Given Consensus Rating of "Moderate Buy" by BrokeragesAugust 19, 2025 | marketbeat.comQ3 Earnings Forecast for Alto Neuroscience Issued By WedbushAugust 19, 2025 | marketbeat.comWilliam Blair Issues Pessimistic Outlook for ANRO EarningsAugust 19, 2025 | marketbeat.comQ3 EPS Forecast for Alto Neuroscience Reduced by AnalystAugust 19, 2025 | americanbankingnews.comAlto Neuroscience, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; September 19, 2025 Deadline to file Lead Plaintiff MotionAugust 18, 2025 | globenewswire.comANRO LAWSUIT ALERT: The Gross Law Firm Notifies Alto Neuroscience, Inc. ...August 18, 2025 | gurufocus.comANRO LAWSUIT ALERT: The Gross Law Firm Notifies Alto Neuroscience, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineAugust 18, 2025 | globenewswire.comLawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Alto Neuroscience, ...August 18, 2025 | gurufocus.comLawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Alto Neuroscience, Inc. (NYSE: ANRO) between Feb. and Oct. 2024 should contact the Shareholders FoundationAugust 18, 2025 | prnewswire.comAlto Neuroscience to Participate in Upcoming Investor ConferencesAugust 18, 2025 | gurufocus.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in ...August 18, 2025 | gurufocus.comANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. ...August 18, 2025 | gurufocus.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. Lawsuit - ANROAugust 18, 2025 | prnewswire.comANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law FirmAugust 18, 2025 | prnewswire.comAlto Neuroscience to Participate in Upcoming Investor ConferencesAugust 18, 2025 | businesswire.comSHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Alto Neuroscience, Inc. (NYSE: ANRO)August 18, 2025 | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. ...August 17, 2025 | gurufocus.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc.and Certain Officers – ANROAugust 17, 2025 | globenewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. ...August 16, 2025 | gurufocus.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANROAugust 16, 2025 | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Alto Neuroscience, Inc. ...August 16, 2025 | gurufocus.com Get Alto Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter. Email Address ANRO Media Mentions By Week ANRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANRO News Sentiment▼0.000.70▲Average Medical News Sentiment ANRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANRO Articles This Week▼405▲ANRO Articles Average Week Get Alto Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fulcrum Therapeutics News Today Abeona Therapeutics News Today Capricor Therapeutics News Today Zhengye Biotechnology News Today ADC Therapeutics News Today Benitec Biopharma News Today 4D Molecular Therapeutics News Today Inhibrx Biosciences News Today Candel Therapeutics News Today Larimar Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ANRO) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access